The historical rank and industry rank for Viet Nam Pharmaceutical - JSC's EV-to-FCF or its related term are showing as below:
HSTC:DVN'
s EV-to-FCF Range Over the Past 10 Years
Min: -269.53 Med: 11.05 Max: 176.25
Current: -17.2
During the past 7 years, the highest EV-to-FCF of Viet Nam Pharmaceutical - JSC was 176.25. The lowest was -269.53. And the median was 11.05.
HSTC:DVN's EV-to-FCF is ranked worse than 100% of 563
companies
in the Drug Manufacturers industry
Industry Median: 20.77
vs HSTC:DVN: -17.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Viet Nam Pharmaceutical - JSC (HSTC:DVN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Viet Nam Pharmaceutical - JSC's PE Ratio (TTM) for today is calculated as:
Viet Nam Pharmaceutical - JSC's share price for today is ₫20000.00.
Viet Nam Pharmaceutical - JSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫2891.109.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Viet Nam Pharmaceutical - JSC EV-to-FCF Related Terms
Viet Nam Pharmaceutical - JSC EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viet Nam Pharmaceutical - JSC EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Viet Nam Pharmaceutical - JSC's EV-to-FCF falls into.
Viet Nam Pharmaceutical - JSC's current Enterprise Value is ₫5,962,581 Mil.
Viet Nam Pharmaceutical - JSC's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫-349,387 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a EV-to-FCF of -17.07 as of Jul. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. According to the industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #999999 out of 563 companies in the Drug Manufacturers industry.
Is Viet Nam Pharmaceutical - JSC's EV-to-FCF too high?
Viet Nam Pharmaceutical - JSC's current EV-to-FCF is -17.07. Based on the distribution chart, Viet Nam Pharmaceutical - JSC ranks #999999 out of 563 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #999999 out of 563 companies for EV-to-FCF. This places Viet Nam Pharmaceutical - JSC in the lower half of its industry. The industry median EV-to-FCF is 20.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.77, based on 563 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viet Nam Pharmaceutical - JSC's current EV-to-FCF is -17.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Fairly Valued. The stock's GF Value™ is ₫22,074.26, compared to a current price of ₫20,000.00 — trading 9.4% below its estimated fair value. The current EV-to-FCF is -17.07. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current EV-to-FCF is -17.07 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued.
The current stock price of ₫20,000.00 is trading 9.4% below its estimated GF Value™ of ₫22,074.26.
GuruFocus considers Viet Nam Pharmaceutical - JSC to be Fairly Valued.
Key valuation signals for HSTC:DVN:
EV-to-FCF: -17.07
GF Value™: ₫22,074.26 vs. price of ₫20,000.00 (9.4% below fair value)
No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viet Nam Pharmaceutical - JSC Business Description
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
79GF Score
Get the complete analysis for HSTC:DVN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVN has been successfully added to your 
